Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2023-11-03 00:00:00 ET · period of report 2023-11-01 · accession 0001209191-23-054355 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-03 | 2023-11-01 | PHAT | Henderson Molly | CFO, CBO | A - Grant | $0.00 | +22.5K | 117.7K | +24% | $0 | |
| M | 2023-11-03 | 2023-11-01 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $8.88 | -12.5K | 105.2K | -11% | -$110.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-01 | A | A | 22,500 | $0.00 | 117,680 | D | — | — | (F1) Represents shares earned with respect to a performance stock unit award granted on January 19, 2023 that contained a performance-vesting requirement that was satisfied on November 1, 2023. |
| 2 | Common | Common Stock | 2023-11-01 | S | D | 811 | $7.80 | 116,869 | D | — | — | (F2) Represents shares sold to satisfy tax withholding obligations upon the settlement of performance stock units. |
| 3 | Common | Common Stock | 2023-11-01 | S | D | 11,681 | $8.95 | 105,188 | D | — | — | (F2) Represents shares sold to satisfy tax withholding obligations upon the settlement of performance stock units. |